ESR1 and ductal breast carcinoma in situ: Canine DCIS and invasive cancer resemble human DCIS and its invasive progression with respect to histopathology, the expression of many tumor markers including estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor (HER2), Ki-67, clinical outcomes, and imaging characteristics [14,15].